Journal of Volgograd State Medical UniversityJournal of Volgograd State Medical University1994-94801994-9499Volgograd State Medical University118742Research ArticleIDENTIFYING PREFERENCES OF CONSUMERS OF OSTEOPOROSIS DRUGS IN THE VOLGOGRAD REGIONGaltsovaE. G.kategaltsova@mail.ru15042014114626416122022Copyright © 2014, Galtsova E.G.2014We analyzed prescription drug therapies for the prevention and treatment of osteoporosis in a total of 234 case records of osteoporosis in- and outpatients between 2010 and 2013. We interviewed 397 health care professionals employed in a variety of medical fields in Volgograd and in the Volgograd region to identify the degree of their awareness of prescription drug therapies for the prevention and treatment of osteoporosis. Rheumatologists and endocrinologists appeared to be better informed about prescription drug therapies for the treatment of osteoporosis than any other health care professionals. Gynecologists appeared to be ill-informed. Most often therapeutists and traumatologists prescribe Alpha D3-teva, Miacalcic and calcium supplements to treat osteoporosis, although bisphosphonates are considered to be the first-line therapy for osteoporosis. Prescriptions made by rheumatologists and endocrinologists were consistent with clinical practice guidelines for the treatment of osteoporosis.osteoporosisbisphosphonatespreferences of health care professionalscalcium supplementsinterviewingrheumatologistsостеопорозбисфосфонатыпредпочтения врачейпрепараты кальцияанкетированиеревматологи[Лесняк О. М. Остеопороз / Под ред. О. М. Лесняк, Л. И. Беневоленской // 2-е изд., перераб. и доп. - М.: ГЭОТАР-Медия, 2012. - 272 с.][Boonen S., Body J. J., Boutsen Y., et al. Evidence-Based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club // Osteoporos Int. - 2005. - Vol. 16. - P. 239-254.][Brown J. P., Josse R. G. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada // CMAJ. - 2002. - Vol. 167 (10 suppl). - P. 1-34.][De Nijs R. N., Jacobs J. W., et al. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies // Osteoporos Int. - 2004. - Vol. 15 (8). - P. 589-602.][European Medicines Agency recommends limiting long-term use of calcitonin medicines. URL: http:// www.ema.europa.eu/doc/483874.][Janghorbani M. Systematic review of type and type 2diabetes mellitus and risk of fractures // Am. J. Epidimiol. - 2007. - Vol. 166 (5). - P. 495-505.][Kanis J. A., Johanson H., Oden A., et al. A meta-analysis of prior corticosteroid use and fracture risk // J. Bone Miner. Res. - 2000. - Vol. 19. - P. 893-899.]